Fusion Fuel Green PLC Files 424B3 Prospectus Update

TL;DR

**Fusion Fuel Green just updated their prospectus, keeping options open for future stock sales.**

AI Summary

Fusion Fuel Green PLC filed a 424B3 prospectus on March 24, 2026, which is a standard update to a previous registration statement (File No. 333-294414). This filing doesn't announce new financial events but rather provides updated information about the company's securities offerings. For current or prospective shareholders, this means the company is maintaining compliance and keeping its options open for future capital raises, which could impact share dilution or provide funds for growth initiatives.

Why It Matters

This filing indicates Fusion Fuel Green PLC is keeping its registration statement current, allowing it flexibility for future capital raises which could fund operations or expansion, potentially impacting shareholder value.

Risk Assessment

Risk Level: low — This is a routine compliance filing and does not inherently introduce new risks, though future offerings could lead to dilution.

Analyst Insight

A smart investor would note this routine filing as a sign of ongoing compliance, but would look for subsequent filings (like a pricing supplement) to understand the specifics of any actual capital raise and its potential impact on share price.

Key Numbers

• 2026-03-24 — Filing Date (Date the 424B3 prospectus was filed)
• 424B3 — Form Type (Type of SEC filing)

Key Players & Entities

• Fusion Fuel Green PLC (company) — the filer of the 424B3 prospectus
• 0001819794 (person) — CIK of Fusion Fuel Green PLC
• 333-294414 (dollar_amount) — File number of the related registration statement

FAQ

Key Financial Figures

• $0.0035 — ordinary shares with a nominal value of $0.0035 each (“Class A Ordinary Shares&rd
• $5 — sable at an exercise price per share of $5.148, without giving effect to applicabl
• $6 — sable at an exercise price per share of $6.864, without giving effect to applicabl
• $8,483,138 — gregate gross proceeds of approximately $8,483,138. We intend to use such proceeds, if and
• $3.05 — aq Capital Market on March 16, 2026 was $3.05. Investing in our securities is highl
• $2,600,000 — any) for an aggregate purchase price of $2,600,000 (such transaction, the “February
• $5,000,000 — ly reasonable efforts to raise at least $5,000,000 in one or more financing transactions (

Filing Documents

• form424b3.htm (424B3) — 262KB
• 0001493152-26-012275.txt ( ) — 263KB

Risk Factors

Risk Factors 4 Cautionary Note Regarding Forward-Looking Statements 5

Use of Proceeds

Use of Proceeds 6 Dividend Policy 7 February 2026 Advisory Agreements 8 February 2026 Private Placement 9

Description of Securities

Description of Securities 9 Selling Shareholders 12 Plan of Distribution 17 Expenses Related to the Offering 18 Legal Matters 18 Experts 19 Indemnification 20 Enforcement of Civil Liabilities 21 Material Changes 22 Where You Can Find More Information; Documents Incorporated by Reference 23 i ABOUT THIS PROSPECTUS This prospectus is part of a registration statement on Form F-3 filed with the U.S. Securities and Exchange Commission (the “SEC”) to register the Registrable Securities for resale by the Selling Shareholders who may, from time to time and subject to applicable limitations, if any, sell such securities. See “ Plan of Distribution ” for more information. We may, from time to time, file one or more prospectus supplements, or, when appropriate, post-effective amendments, to update, add to, or otherwise modify the information in this prospectus. If a prospectus supplement or post-effective amendment conflicts with any statement in this prospectus, the newer document will control. We may also authorize one or more free writing prospectuses that provide additional material information about this offering. Accordingly, you should read this prospectus together with any prospectus supplement, any post-effective amendment, and any related free writing prospectus, and all information that we incorporate by reference or attach to those documents. See “ Where You Can Find More Information; Documents Incorporated by Reference ” for more information. You are also strongly urged to review carefully the matters discussed under “ Risk Factors ” in this prospectus, in each prospectus supplement, in any post-effective amendment, in any related free writing prospectus, and in any other documents that we incorporate by reference. Neither we, nor the Selling Shareholders, have authorized anyone to provide you with any information or to make any representations other than those contained in this

RISK FACTORS

RISK FACTORS An investment in the Class A Ordinary Shares involves a high degree of risk. You should carefully consider the information set forth under Item 3.D. “Risk Factors” of the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2024 filed with the SEC on May 9, 2025, which is incorporated by reference herein except to the extent that the risk factors stated therein are amended, restated or updated hereby, and in other filings we make with the SEC, before purchasing the Class A Ordinary Shares. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our operations. 4 CAUTIONARY NOTE REGARDING

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS This prospectus contains or may incorporate by reference, and any prospectus supplement or documents incorporated by reference herein or therein may contain or incorporate by reference, forward-looking statements within the meaning of Section 21E of the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 27A of the U.S. Securities Act of 1933, as amended (the “Securities Act”), that are based on our management’s beliefs and assumptions and on information available to us on the date of such events or to our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include, but are not limited to, statements about: our goals and growth strategies; our future prospects and market acceptance of products and services; our future business development, financial condition and results of operations; changes in our revenue, costs or expenditures; our expectations regarding the demand for, and market acceptance of, our products and services; general economic and business conditions in the markets in which we operate; growth and competition in the markets in which we operate; relevant government policies and regulations relating to our business and industry; our ability to obtain additional financing when and if needed; and the assumptions underlying or related to any of the foregoing. In some cases, you can identify forward-looking statements by terms such as “may,” “could,” “will,” “should

USE OF PROCEEDS

USE OF PROCEEDS We are registering the Registrable Securities pursuant to the February 2026 Advisory Agreements and the February 2026 Securities Purchase Agreement and the resale registration provisions contained therein. Accordingly, we are not selling any securities under this prospectus and will not receive any proceeds from the sale of any Registrable Securities. Notwithstanding the foregoing, we may receive proceeds upon any cash exercise of the Advisor Pre-Funded Warrants and February 2026 Warrants. If the warrants are exercised in full for cash at their exercise prices as of the date of this prospectus, we would receive aggregate gross proceeds of approximately 8,483,138. We intend to use such proceeds, if and when received, for working capital and general corporate purposes. Notwithstanding the foregoing, as of the date of this prospectus, we cannot specify with certainty all of the particular uses, and the respective amounts we may allocate to those uses, for any net proceeds we receive from any exercise of the Advisor Pre-Funded Warrants and the February 2026 Warrants. Accordingly, we will retain broad discretion over the use of these proceeds. Under the Stock Purchase Agreement, dated as of November 18, 2024 (the “QIND Purchase Agreement”), among the Company, Quality Industrial Corp., a Nevada corporation (“QIND”), Ilustrato Pictures International Inc., a Nevada corporation, and certain other stockholders of QIND, the Company is required to use commercially reasonable efforts to raise at least $5,000,000 in one or more financing transactions (“Purchaser Financing”). 50% of the proceeds from the Purchaser Financing will be set aside and made available expressly for QIND to use for its working capital and corporate needs and the remaining 50% of such funds will be set aside and made available expressly for the businesses of the Company existing immediately prior to the closing under the QIND Purchase Agreement to use

View Full Filing

View this 424B3 filing on SEC EDGAR